Status:

COMPLETED

Using Mobile Technology to Improve Self-Regulation

Lead Sponsor:

Dartmouth-Hitchcock Medical Center

Collaborating Sponsors:

National Institutes of Health (NIH)

National Institute on Drug Abuse (NIDA)

Conditions:

Self-regulation

Binge Eating

Eligibility:

All Genders

18-50 years

Phase:

NA

Brief Summary

This study will evaluate the degree to which engaging targets produces a desired change in medical regimen adherence (across 4-week interventions) and health behavior among smokers (n=50) and overweig...

Detailed Description

Health risk behavior, including poor diet, physical inactivity, tobacco and other substance use, causes as much as 40% of the illness, suffering, and early death related to chronic diseases. Non-adher...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Age 18-50 years
  • Understand English sufficiently to provide informed consent
  • Access to a computer in a setting in which the participant is comfortable providing sensitive information
  • Use a smartphone operating system compatible with Laddr
  • Additional inclusion criteria for binge eating sample:
  • 27 ≤ BMI ≤ 45 kg/m2
  • Have binge eating disorder according to DSM-5 criteria
  • Non-smoking (defined as no cigarettes in past 12 months-this includes former and never smokers)
  • Confirmed interest in an eating intervention
  • Use a smartphone compatible with Fitbit
  • Additional inclusion criteria for smoking sample:
  • Smoke 5 or more tobacco cigarettes/day for past year
  • 17 ≤ BMI \< 27 kg/m2
  • Confirmed interest in a smoking quit attempt
  • Use a smartphone compatible with the iCO Smokerlyzer
  • Exclusion criteria:
  • Enrolled in Aim 2 study
  • Any current substance use disorder
  • o Will not exclude based on use of substances
  • Currently pregnant or plans to become pregnant in next 3 months
  • Lifetime history of mental disorder due to a medical condition
  • Lifetime history of major psychotic disorders (including schizophrenia and bipolar disorder)
  • Current use of prescription pain medications (e.g., Vicodin, oxycodone)
  • Current use of any medication for smoking (e.g., Wellbutrin, varenicline)
  • o Exceptions: will not screen out for nicotine replacement therapy (e.g., patch, gum, lozenge, nasal spray, inhaler)
  • Current use of any medication for weight loss
  • Have undergone weight-loss surgery (e.g., gastric bypass, lap band)
  • Current nighttime shift work or obstructive sleep apnea
  • Note: We will not exclude based on e-cigarette use.
  • Additional exclusion criteria for binge eating sample:
  • Compensatory behavior (e.g., purging, excessive exercise, fasting)
  • o Already excluded as part of the DSM-5 binge eating disorder criteria
  • Lost weight in recent past (\>10 pounds in past 6 months)
  • Currently in a weight-loss program (e.g., Weight Watchers, Jenny Craig)
  • o Will ask about, but won't exclude on, online/mobile app weight-loss programs as part of the screener
  • Currently on a special diet for a serious health condition
  • Currently in therapy with a clinician for binge eating
  • Nickel allergy (because Fitbit band contains nickel)
  • Additional exclusion criteria for smoking sample:
  • Currently in therapy with a clinician for smoking
  • Binge eating behavior

Exclusion

    Key Trial Info

    Start Date :

    February 27 2019

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    June 29 2020

    Estimated Enrollment :

    114 Patients enrolled

    Trial Details

    Trial ID

    NCT03774433

    Start Date

    February 27 2019

    End Date

    June 29 2020

    Last Update

    August 24 2021

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Center for Technology and Behavioral Health, Dartmouth College

    Lebanon, New Hampshire, United States, 03766